<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02314572</url>
  </required_header>
  <id_info>
    <org_study_id>EA1/124/13</org_study_id>
    <nct_id>NCT02314572</nct_id>
  </id_info>
  <brief_title>Visual Acuity After the Combined Binocular Implantation of +2.5 Diopters and +3.0 Diopters ReSTOR Multifocal Intraocular Lenses.</brief_title>
  <official_title>Evaluation of the Visual Acuity After the Implantation of a ReSTOR +2.5 Diopters Intraocular Lens (ReSTOR SV25T0) in the Distance Dominant Eye, in Combination With a +3.0 Diopters ReSTOR Intraocular Lens (ReSTOR SN6AD1) in the Fellow Eye.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to assess the visual outcome after the combined binocular
      implantation of +2.5 D and +3.0 D apodized diffractive multifocal intraocular lenses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bifocal multifocal intraocular lenses (MIOL) are effective in achieving good uncorrected
      visual acuities in the distance and the near. However, the intermediate vision is of
      increasing relevance for everyday's life. Several multifocal intraocular lenses have been
      developed to improvement intermediate vision. Nonetheless, those systems still possess
      adverse photic effects and do not garantuee spectacle independence. Therefore, the
      combination of a lower-addition bifocal intraocular lense in the distance-dominant eye with a
      higher-addition bifocal intraocular lense in the fellow-eye might be a promising approach to
      address these drawbacks of current binocular and trifocal intraocular lenses.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuities in the far, intermediate and near</measure>
    <time_frame>1 month</time_frame>
    <description>Visual acuities are tested under photopic conditions at 5 m, intermediate (80 cm) and patient-preferred near distance (≈ 40 cm).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual acuities in the far, intermediate and near</measure>
    <time_frame>3 months</time_frame>
    <description>Visual acuities are tested under photopic conditions at 5 m, intermediate (80 cm) and patient-preferred near distance (≈ 40 cm).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mesopic vision</measure>
    <time_frame>1 month</time_frame>
    <description>Mesopic visual acuities are tested under high-contrast, low-contrast and low-contrast with glare.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mesopic vision</measure>
    <time_frame>3 months</time_frame>
    <description>Mesopic visual acuities are tested under high-contrast, low-contrast and low-contrast with glare.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Scotopic contrast sensitivity</measure>
    <time_frame>1 month</time_frame>
    <description>Scotopic contrast sensitivity are tested at 0.1 cd/m2, 0.032 cd/m2 and 0.1 cd/m2 with glare.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Scotopic contrast sensitivity</measure>
    <time_frame>3 months</time_frame>
    <description>Scotopic contrast sensitivity are tested at 0.1 cd/m2, 0.032 cd/m2 and 0.1 cd/m2 with glare.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spectacle independence in the far, intermediate and near</measure>
    <time_frame>3 months</time_frame>
    <description>Spectacle independence as stated by the patient.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Single-arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Binocular cataract surgery with phacoemulsification and implantation of multifocal intraocular lenses</intervention_name>
    <description>Binocular implantation of the combination of AcrySof® IQ ReSTOR® multifocal intraocular lenses with an addition of +2.5 D in the distance-dominant eye and +3.0 D in the fellow eye.</description>
    <arm_group_label>Single-arm</arm_group_label>
    <other_name>AcrySof® IQ ReSTOR® multifocal intraocular lenses with an addition of +2.5 D (SV25-type) and +3.0 D (SN6A-type) are used.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinically significant cataract

          -  endothelial cell count: patients aged 18-75 years: &gt; 1000 cells/mm2; patients &gt; 75
             years: &gt; 750 cells/mm2

          -  absence of vision-limiting corneal or retinal comorbidities

          -  capability to understand the informed consent

        Exclusion Criteria:

          -  expected postoperative astigmatism &gt; 0.75 diopters

          -  irregular astigmatism

          -  dilated pupil diameter &lt; 3 mm

          -  corneal and fundus abnormalities that might cause visual impairments

          -  inability to attend follow-up visits
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eckart Bertelmann, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>eckart.bertelmann@charite.de</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tobias Brockmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>tobias.brockmann@charite.de</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charité - University Medicine Berlin, Department of Ophthalmology</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Pedrotti E, Mastropasqua R, Passilongo M, Parisi G, Marchesoni I, Marchini G. Comparison of two multifocal intraocular lens designs that differ only in near add. J Refract Surg. 2014 Nov;30(11):754-60. doi: 10.3928/1081597X-20141021-07.</citation>
    <PMID>25375848</PMID>
  </reference>
  <reference>
    <citation>Alfonso JF, Knorz M, Fernandez-Vega L, Rincón JL, Suarez E, Titke C, Kohnen T. Clinical outcomes after bilateral implantation of an apodized +3.0 D toric diffractive multifocal intraocular lens. J Cataract Refract Surg. 2014 Jan;40(1):51-9. doi: 10.1016/j.jcrs.2013.06.026.</citation>
    <PMID>24355720</PMID>
  </reference>
  <reference>
    <citation>Javitt JC, Steinert RF. Cataract extraction with multifocal intraocular lens implantation: a multinational clinical trial evaluating clinical, functional, and quality-of-life outcomes. Ophthalmology. 2000 Nov;107(11):2040-8.</citation>
    <PMID>11054329</PMID>
  </reference>
  <reference>
    <citation>Vingolo EM, Grenga P, Iacobelli L, Grenga R. Visual acuity and contrast sensitivity: AcrySof ReSTOR apodized diffractive versus AcrySof SA60AT monofocal intraocular lenses. J Cataract Refract Surg. 2007 Jul;33(7):1244-7.</citation>
    <PMID>17586381</PMID>
  </reference>
  <reference>
    <citation>Cillino G, Casuccio A, Pasti M, Bono V, Mencucci R, Cillino S. Working-age cataract patients: visual results, reading performance, and quality of life with three diffractive multifocal intraocular lenses. Ophthalmology. 2014 Jan;121(1):34-44. doi: 10.1016/j.ophtha.2013.06.034. Epub 2013 Aug 14.</citation>
    <PMID>23953097</PMID>
  </reference>
  <reference>
    <citation>Chiam PJ, Chan JH, Aggarwal RK, Kasaby S. ReSTOR intraocular lens implantation in cataract surgery: quality of vision. J Cataract Refract Surg. 2006 Sep;32(9):1459-63. Erratum in: J Cataract Refract Surg. 2006 Dec;32(12):1987.</citation>
    <PMID>16931256</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2014</study_first_submitted>
  <study_first_submitted_qc>December 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2014</study_first_posted>
  <last_update_submitted>December 15, 2015</last_update_submitted>
  <last_update_submitted_qc>December 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>PD Dr. med. Eckart Bertelmann</investigator_full_name>
    <investigator_title>managing senior physician</investigator_title>
  </responsible_party>
  <keyword>Multifocal Intraocular Lens</keyword>
  <keyword>Binocular Trifocality</keyword>
  <keyword>Cataract Surgery</keyword>
  <keyword>Spectacle Independence</keyword>
  <keyword>Intermediate Vision</keyword>
  <keyword>Photopic Vision</keyword>
  <keyword>Mesopic Vision</keyword>
  <keyword>Scotopic Vision</keyword>
  <keyword>Binocular Vision</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

